Neurogenic Thoracic Outlet Syndrome in Division 1 Collegiate Athletes: Presentation, Diagnosis, and Treatment
- 19 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
- Vol. 33 (5) , 467-474
Abstract
Objective: Athletes who engage in repetitive upper-extremity exercise are susceptible to neurogenic thoracic outlet syndrome (nTOS). We sought to identify typical presenting symptoms and common findings on diagnostic workup, in addition to evaluating rates of return to play following various treatment interventions. Design: Retrospective chart review. Setting: Single institution. Participants: Medical records of Division 1 athletes containing the diagnosis of nTOS between the years 2000 and 2020 were identified. Athletes with arterial or venous thoracic outlet syndrome were excluded. Independent Variables: Demographics, sport, participation status, clinical presentation, physical examination findings, diagnostic workup, and treatments provided. Main Outcome Measures: Rate of return to play (RTP) to collegiate athletics. Results: Twenty-three female and 13 male athletes were diagnosed and treated for nTOS. Digit plethysmography showed diminished or obliterated waveforms with provocative maneuvers in 23 of 25 athletes. Forty-two percent were able to continue competing despite symptoms. Of the athletes who were initially unable to compete, 12% returned to full competition after physical therapy alone, 42% of those remaining were able to RTP after botulinum toxin injection, and an additional 42% of the remaining athletes RTP after thoracic outlet decompression surgery. Conclusions: Many athletes diagnosed with nTOS will be able to continue competing despite symptoms. Digit plethysmography is a sensitive diagnostic tool for nTOS to document anatomical compression at the thoracic inlet. Botulinum toxin injection had a significant positive effect on symptoms and a high rate of RTP (42%), allowing numerous athletes to avoid surgery and its prolonged recovery and associated risks. Clinical Relevance: This study demonstrates that botulinum toxin injection had a high rate of return to full competition in elite athletes without the risks and recovery needed for surgical intervention, suggesting that this may be a good intervention especially among elite athletes who only experience symptoms with sport-related activities.Keywords
This publication has 21 references indexed in Scilit:
- Specificity of the minimal clinically important difference of the quick Disabilities of the Arm Shoulder and Hand (QDASH) for distal upper extremity conditionsJournal of Hand Therapy, 2016
- Thoracic Outlet SyndromeJournal of the American Academy of Orthopaedic Surgeons, 2015
- Neurologic Thoracic Outlet SyndromeOptometry and Vision Science, 2014
- Management of unresolved, recurrent, and/or contralateral neurogenic symptoms in patients following first rib resection and scalenectomyJournal of Vascular Surgery, 2012
- Early results of a highly selective algorithm for surgery on patients with neurogenic thoracic outlet syndromeJournal of Vascular Surgery, 2011
- Botulinum toxin injection for management of thoracic outlet syndrome: A double-blind, randomized, controlled trialPain, 2011
- Thoracic Outlet Syndrome: Definition, Aetiological Factors, Diagnosis, Management and Occupational ImpactJournal of Occupational Rehabilitation, 2010
- Thoracic outlet syndrome Part 2: Conservative management of thoracic outletManual Therapy, 2010
- Single CT-Guided Chemodenervation of the Anterior Scalene Muscle with Botulinum Toxin for Neurogenic Thoracic Outlet SyndromePain Medicine, 2010
- Diagnosis of thoracic outlet syndromeJournal of Vascular Surgery, 2007